{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:09:20Z","timestamp":1784300960681,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10120-2","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:56:55Z","timestamp":1784296615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AURKA regulates HBV-induced hepatic stellate cell inflammation and liver fibrosis by modulating K48-linked ubiquitination and proteasomal degradation of TLR3"],"prefix":"10.1007","volume":"58","author":[{"given":"Hongjie","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianbao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyun","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"10120_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12032-022-01852-3","volume":"39","author":"A Almilaibary","year":"2022","unstructured":"Almilaibary A (2022) Targeting aurora kinase a (AURKA) in cancer: molecular docking and dynamic simulations of potential AURKA inhibitors. Med Oncol 39:246","journal-title":"Med Oncol"},{"key":"10120_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/ph18081201","volume":"18","author":"F Alqussair","year":"2025","unstructured":"Alqussair F, Elshal M, Makled MN, Abu-Elsaad NM (2025) The AURKA-Selective Inhibitor Alisertib Attenuates Doxorubicin-Induced Hepatotoxicity in Mice via Modulation of IL-17A\/NF-\u03baB and STAT3 Signaling Pathways. Pharmaceuticals (Basel) 18:1201","journal-title":"Pharmaceuticals (Basel)"},{"key":"10120_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jhep.2012.09.016","volume":"58","author":"JS Byun","year":"2013","unstructured":"Byun JS, Suh YG, Yi HS, Lee YS, Jeong WI (2013) Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. J Hepatol 58:342\u2013349","journal-title":"J Hepatol"},{"key":"10120_CR4","doi-asserted-by":"publisher","first-page":"e0310625","DOI":"10.1371\/journal.pone.0310625","volume":"19","author":"R Cacioppo","year":"2024","unstructured":"Cacioppo R, Rad D, Pagani G, Gandellini P, Lindon C (2024) Post-transcriptional control drives Aurora kinase A expression in human cancers. PLoS ONE 19:e0310625","journal-title":"PLoS ONE"},{"key":"10120_CR5","doi-asserted-by":"publisher","first-page":"113929","DOI":"10.1016\/j.intimp.2024.113929","volume":"147","author":"JY Cheng","year":"2025","unstructured":"Cheng JY, Shan GY, Wan H, Zhang YX, Gao ZC, Shi YP et al (2025) MIF\/CD74 axis in hepatic stellate cells mediates HBV-related liver fibrosis. Int Immunopharmacol 147:113929","journal-title":"Int Immunopharmacol"},{"key":"10120_CR6","doi-asserted-by":"publisher","first-page":"1517226","DOI":"10.3389\/fonc.2024.1517226","volume":"14","author":"G Dai","year":"2024","unstructured":"Dai G, Lin J, Jiang Y, Liu X, Chen P, Zhang Y et al (2024) Aurora kinase A promotes hepatic stellate cell activation and liver fibrosis through the Wnt\/\u03b2-catenin pathway. Front Oncol 14:1517226","journal-title":"Front Oncol"},{"key":"10120_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12951-024-03070-7","volume":"22","author":"B Deng","year":"2024","unstructured":"Deng B, Ke B, Tian Q, Gao Y, Zhai Q, Zhang W (2024) Targeting AURKA with multifunctional nanoparticles in CRPC therapy. J Nanobiotechnol 22:803","journal-title":"J Nanobiotechnol"},{"key":"10120_CR8","doi-asserted-by":"publisher","first-page":"1486357","DOI":"10.3389\/fphar.2025.1486357","volume":"16","author":"H Gao","year":"2025","unstructured":"Gao H, Sun Z, Hu X, Song W, Liu Y, Zou M et al (2025) Identification of glycolysis-related gene signatures for prognosis and therapeutic targeting in idiopathic pulmonary fibrosis. Front Pharmacol 16:1486357","journal-title":"Front Pharmacol"},{"key":"10120_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41419-026-08549-9","volume":"17","author":"J Gao","year":"2026","unstructured":"Gao J, Zhang W, Chen L, Pu R, Huang S, Wu X et al (2026) AURKA-mediated destabilization of SAPS3 drives ferroptosis evasion via 7-dehydrocholesterol biosynthesis in colorectal cancer. Cell Death Dis 17:361","journal-title":"Cell Death Dis"},{"key":"10120_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1139\/cjm-2016-0129","volume":"62","author":"EF Goktas","year":"2016","unstructured":"Goktas EF, Bulut C, Goktas MT, Ozer EK, Karaca RO, Kinikli S et al (2016) Investigation of 1377\u00a0C\/T polymorphism of the Toll-like receptor 3 among patients with chronic hepatitis B. Can J Microbiol 62:617\u2013622","journal-title":"Can J Microbiol"},{"key":"10120_CR11","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/v13061103","volume":"13","author":"KS Guedes de S\u00e1","year":"2021","unstructured":"Guedes de S\u00e1 KS, Amoras E, Conde S, Queiroz MAF, Cayres-Vallinoto IMV, Ishak R et al (2021) Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C. Viruses 13:1103","journal-title":"Viruses"},{"key":"10120_CR12","doi-asserted-by":"publisher","first-page":"1147379","DOI":"10.3389\/fimmu.2023.1147379","volume":"14","author":"M He","year":"2023","unstructured":"He M, Chu T, Wang Z, Feng Y, Shi R, He M et al (2023) Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis. Front Immunol 14:1147379","journal-title":"Front Immunol"},{"key":"10120_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3350\/cmh.2022.0422","volume":"29","author":"SC Huang","year":"2023","unstructured":"Huang SC, Liu CJ (2023) Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives. Clin Mol Hepatol 29:320\u2013331","journal-title":"Clin Mol Hepatol"},{"key":"10120_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3851\/IMP2630","volume":"18","author":"YW Huang","year":"2013","unstructured":"Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH et al (2013) Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir Ther 18:877\u2013884","journal-title":"Antivir Ther"},{"key":"10120_CR15","doi-asserted-by":"publisher","first-page":"166227","DOI":"10.1016\/j.bbadis.2021.166227","volume":"1867","author":"M Jiang","year":"2021","unstructured":"Jiang M, Bai M, Xu S, Wang T, Lei J, Xu M et al (2021a) Blocking AURKA with MK-5108 attenuates renal fibrosis in chronic kidney disease. Biochim Biophys Acta Mol Basis Dis 1867:166227","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10120_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7150\/thno.46360","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Xiang C, Zhong F, Zhang Y, Wang L, Zhao Y et al (2021b) Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics 11:361\u2013378","journal-title":"Theranostics"},{"key":"10120_CR17","doi-asserted-by":"publisher","first-page":"115317","DOI":"10.1016\/j.celrep.2025.115317","volume":"44","author":"TJ Kucharski","year":"2025","unstructured":"Kucharski TJ, Vlasac IM, Lyalina T, Higgs MR, Christensen BC, Bechstedt S et al (2025) An Aurora kinase A-BOD1L1-PP2A B56 axis promotes chromosome segregation fidelity. Cell Rep 44:115317","journal-title":"Cell Rep"},{"key":"10120_CR18","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","volume":"66","author":"F Leboss\u00e9","year":"2017","unstructured":"Leboss\u00e9 F, Testoni B, Fresquet J, Facchetti F, Galmozzi E, Fournier M et al (2017) Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. J Hepatol 66:897\u2013909","journal-title":"J Hepatol"},{"key":"10120_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","volume":"81","author":"KR LeFort","year":"2024","unstructured":"LeFort KR, Rungratanawanich W, Song BJ (2024) Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell Mol Life Sci 81:34","journal-title":"Cell Mol Life Sci"},{"key":"10120_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41423-021-00801-w","volume":"19","author":"Y Li","year":"2022","unstructured":"Li Y, He M, Wang Z, Duan Z, Guo Z, Wang Z et al (2022) STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis. Cell Mol Immunol 19:92\u2013107","journal-title":"Cell Mol Immunol"},{"key":"10120_CR21","doi-asserted-by":"publisher","first-page":"e23091","DOI":"10.1096\/fj.202300623R","volume":"37","author":"Z Li","year":"2023","unstructured":"Li Z, Hao J, Li L, Shen N, Wang D, Wang N et al (2023) Loss of FUT8 in renal tubules ameliorates ischemia-reperfusion injury-induced renal interstitial inflammation transition to fibrosis via the TLR3-NF-\u03baB pathway. FASEB J 37:e23091","journal-title":"FASEB J"},{"key":"10120_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yexcr.2017.08.001","volume":"359","author":"Y Liu","year":"2017","unstructured":"Liu Y, Li L, Liu J, She WM, Shi JM, Li J et al (2017) Activated hepatic stellate cells directly induce pathogenic Th17 cells in chronic hepatitis B virus infection. Exp Cell Res 359:129\u2013137","journal-title":"Exp Cell Res"},{"key":"10120_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.7150\/ijbs.80461","volume":"19","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wu B, Liu X, Wu X, Du J, Xia G et al (2023) CD73\/NT5E-mediated ubiquitination of AURKA regulates alcohol-related liver fibrosis via modulating hepatic stellate cell senescence. Int J Biol Sci 19:950\u2013966","journal-title":"Int J Biol Sci"},{"key":"10120_CR24","doi-asserted-by":"publisher","first-page":"1477646","DOI":"10.3389\/fimmu.2024.1477646","volume":"15","author":"L Ma","year":"2024","unstructured":"Ma L, Han Q, Cheng L, Song H, Qiang R, Xu P et al (2024) Altered mitochondrial mass and low mitochondrial membrane potential of immune cells in patients with HBV infection and correlation with liver inflammation. Front Immunol 15:1477646","journal-title":"Front Immunol"},{"key":"10120_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","volume":"155","author":"A Mansouri","year":"2018","unstructured":"Mansouri A, Gattolliat CH, Asselah T (2018) Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases. Gastroenterology 155:629\u2013647","journal-title":"Gastroenterology"},{"key":"10120_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.202010-3880OC","volume":"205","author":"AN McElroy","year":"2022","unstructured":"McElroy AN, Invernizzi R, Laskowska JW, O\u2019Neill A, Doroudian M, Moghoofei M et al (2022) Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 205:550\u2013562","journal-title":"Am J Respir Crit Care Med"},{"key":"10120_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s12276-021-00635-6","volume":"53","author":"PK Mou","year":"2021","unstructured":"Mou PK, Yang EJ, Shi C, Ren G, Tao S, Shim JS (2021) Aurora kinase A, a synthetic lethal target for precision cancer medicine. Exp Mol Med 53:835\u2013847","journal-title":"Exp Mol Med"},{"key":"10120_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3390\/biom13081208","volume":"13","author":"M Ogunnaike","year":"2023","unstructured":"Ogunnaike M, Das S, Raut SS, Sultana A, Nayan MU, Ganesan M et al (2023) Chronic Hepatitis B Infection: New Approaches towards Cure. Biomolecules 13:1208","journal-title":"Biomolecules"},{"key":"10120_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.breast.2023.01.010","volume":"69","author":"F Richard","year":"2023","unstructured":"Richard F, De Schepper M, Maetens M, Leduc S, Isnaldi E, Geukens T et al (2023) Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target. Breast 69:476\u2013480","journal-title":"Breast"},{"key":"10120_CR30","doi-asserted-by":"publisher","first-page":"e0042424","DOI":"10.1128\/jvi.00424-24","volume":"98","author":"A Schollmeier","year":"2024","unstructured":"Schollmeier A, Basic M, Glitscher M, Hildt E (2024) The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype. J Virol 98:e0042424","journal-title":"J Virol"},{"key":"10120_CR31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/hep.28644","volume":"64","author":"W Seo","year":"2016","unstructured":"Seo W, Eun HS, Kim SY, Yi HS, Lee YS, Park SH et al (2016) Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by \u03b3\u03b4 T cells in liver fibrosis. Hepatology 64:616\u2013631","journal-title":"Hepatology"},{"key":"10120_CR32","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1038\/s41467-023-42058-z","volume":"14","author":"Y Tsuchiya","year":"2023","unstructured":"Tsuchiya Y, Seki T, Kobayashi K, Komazawa-Sakon S, Shichino S, Nishina T et al (2023) Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis. Nat Commun 14:6304","journal-title":"Nat Commun"},{"key":"10120_CR33","doi-asserted-by":"publisher","first-page":"e0011325","DOI":"10.1371\/journal.pntd.0011325","volume":"17","author":"Y Wang","year":"2023","unstructured":"Wang Y, Gong P, Zhang X, Wang X, Zhang X, Zhang N et al (2023) TLR3 activation by Clonorchis sinensis infection alleviates the fluke-induced liver fibrosis. PLoS Negl Trop Dis 17:e0011325","journal-title":"PLoS Negl Trop Dis"},{"key":"10120_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/nm.3995","volume":"21","author":"QJ Wen","year":"2015","unstructured":"Wen QJ, Yang Q, Goldenson B, Malinge S, Lasho T, Schneider RK et al (2015) Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med 21:1473\u20131480","journal-title":"Nat Med"},{"key":"10120_CR35","doi-asserted-by":"publisher","first-page":"e83391","DOI":"10.1371\/journal.pone.0083391","volume":"9","author":"CL Wilson","year":"2014","unstructured":"Wilson CL, Mann J, Walsh M, Perrugoria MJ, Oakley F, Wright MC et al (2014) Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3. PLoS ONE 9:e83391","journal-title":"PLoS ONE"},{"key":"10120_CR36","doi-asserted-by":"publisher","first-page":"e70953","DOI":"10.1096\/fj.202500241R","volume":"39","author":"D Xia","year":"2025","unstructured":"Xia D, Yu C, Zhou XP, Huang L, Yang S (2025) Inflammation Inhibits HECTD1-Mediated AURKA Ubiquitination to Cause Extracellular Matrix Degradation in Osteoarthritis via Enhancing Cap-Dependent mRNA Translation of ADAMTS12. FASEB J 39:e70953","journal-title":"FASEB J"},{"key":"10120_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jhep.2024.02.018","volume":"81","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang J, Wan J, Cheng Q, Cheng Z, Zhou X et al (2024) PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice. J Hepatol 81:120\u2013134","journal-title":"J Hepatol"},{"key":"10120_CR38","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.3748\/wjg.v26.i27.3917","volume":"26","author":"QY Yao","year":"2020","unstructured":"Yao QY, Feng YD, Han P, Yang F, Song GQ (2020) Hepatic microenvironment underlies fibrosis in chronic hepatitis B patients. World J Gastroenterol 26:3917\u20133928","journal-title":"World J Gastroenterol"},{"key":"10120_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12964-023-01091-7","volume":"21","author":"H You","year":"2023","unstructured":"You H, Wang X, Ma L, Zhang F, Zhang H, Wang Y et al (2023) Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Commun Signal 21:70","journal-title":"Cell Commun Signal"},{"key":"10120_CR40","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2023.05.043","volume":"79","author":"X Zhang","year":"2023","unstructured":"Zhang X, Sharma P, Maschmeyer P, Hu Y, Lou M, Kim J et al (2023) GARP on hepatic stellate cells is essential for the development of liver fibrosis. J Hepatol 79:1214\u20131225","journal-title":"J Hepatol"},{"key":"10120_CR41","doi-asserted-by":"publisher","first-page":"1206720","DOI":"10.3389\/fcimb.2023.1206720","volume":"13","author":"P Zheng","year":"2023","unstructured":"Zheng P, Dou Y, Wang Q (2023) Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. Front Cell Infect Microbiol 13:1206720","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10120-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10120-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:01:59Z","timestamp":1784300519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10120-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10120"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10120-2","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human study: The study protocol involving human specimens was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Henan Medical University. The study was conducted strictly in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients before sample collection. All tissue specimens were fully anonymized to protect patient privacy and were only used for the basic scientific research of this study, not for other purposes.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the animal experiments was granted by the Animal Ethics Committee of the First Affiliated Hospital of Henan Medical University. The animal study strictly followed the ARRIVE guidelines and the 3Rs principle (Replacement, Reduction, Refinement). All surgical procedures were performed under standardized anesthesia, and every effort was made to minimize animal pain and stress. Humane euthanasia was conducted at the end of experiments in accordance with the national standard \u201cGuidelines for Ethical Review of Laboratory Animal Welfare\u201d (GB\/T 35892-2018).","order":4,"name":"Ethics","label":"Animal study","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"38"}}